INOVAIT opens Pilot Fund program to support Canadian image-guided therapy and artificial intelligence projects

Jan 13, 2025
Dr. Kullervo Hynynen smiling and standing at a podium labeled INOVAIT in brightly lit and windowed conference room.

INOVAIT, the Canadian image-guided therapy (IGT) and AI network, is opening a call for applications for its Pilot Fund. The INOVAIT Pilot Fund is a reimbursement-based funding program to support collaborative research and development (R&D) projects that apply artificial intelligence, machine learning, or big data to IGT technologies.

The Pilot Fund aims to help initiate the most promising IGT projects to help improve patient outcomes and fuel economic development in Canada. This funding supports short-term IGT commercialization-oriented R&D projects. Applying organizations can request up to $150,000 of non-dilutive investment, with INOVAIT contributing up to one-third of eligible supported costs in reimbursement funding.

To date, the INOVAIT Pilot Fund has committed just under $8M to support 65 IGT projects across the country. Pilot Fund projects are selected based on their ability to demonstrate exceptional scientific, clinical, and technical merit, and their potential for high commercialization and economic impact.

“The INOVAIT Pilot Fund is a proven medtech advancement program that accelerates the commercialization of Canada’s most innovative and impactful medical technologies,” states Kullervo Hynynen, Co-Executive Director of INOVAIT. “With each new round of the Pilot Fund, our enthusiasm grows as we discover and support groundbreaking medical technologies emerging from Canada’s leading companies, hospitals and universities.”

Funding for the INOVAIT is provided through the Government of Canada’s Strategic Innovation Fund.

This competition is open to Canadian corporations, academic institutions, hospitals, and not-for-profit organizations. To learn more about this funding opportunity, visit www.inovait.ca/funding.

Interested applicants can apply by registering with the INOVAIT Funding Portal at http://inovait.smartsimple.ca. Interested parties must submit their proposal through this portal between February 5, 2025, and April 2, 2025.

INOVAIT will host an online information session on February 12, 2025, at 2:30 pm Eastern Standard Time. Interested applicants are encouraged to register for this webinar to learn more about this unique funding opportunity. Registration for the webinar can be found here.

The live webinar will be hosted in English only. A recording, with both English and French captioning, will be available after the webinar at https://www.youtube.com/@INOVAITCanada.

Share this on social media

Learn more about the network

How 16 Bit harnessed AI to prevent costly fractures, one X-ray at a time

How 16 Bit harnessed AI to prevent costly fractures, one X-ray at a time

As with many transformative businesses, 16 Bit came to be because of, sure, the brilliance and vision of its founders, but also a great deal of serendipity. 16 Bit might not exist had Dr. Mark Cicero and Dr. Alexander Bilbily not both chosen to pursue medical school (with backgrounds in engineering and computer science, respectively), had they not both decided to specialize in radiology, and had they not ended up in the same residency training program at the University of Toronto.

INOVAIT reveals Canada’s strategic advantages in image-guided therapy and artificial intelligence in latest report

INOVAIT reveals Canada’s strategic advantages in image-guided therapy and artificial intelligence in latest report

INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to share their latest report titled, ‘Unlocking Medtech’s Potential: Canada’s Strategic Advantages in Image-Guided Therapy & AI’. Through synthesized insights from interviews with founders and executives from 30 IGT companies in the INOVAIT Network, this new report uncovers the untapped potential of the image-guided therapy sector in Canada.